Montana Clinical Trials Report — April 2026

For Montanans considering clinical trial participation, April 2026 brings a critical deadline for several studies. A total of 9 trials are set to conclude enrollment within the next 90 days, presenting a limited window for those interested in contributing to medical research. These rapidly closing opportunities do not include any trials currently seeking healthy volunteers, meaning participation is focused on individuals with specific health conditions.

Patients managing certain health challenges should note these impending deadlines. The conditions with trials closing soon span various complex medical areas, from advanced cancers to chronic respiratory and immune disorders. Conditions affected include:

• Stage IV lung cancer AJCC V8
• Anatomic Stage II breast cancer AJCC V8
• Anatomic Stage III breast cancer AJCC V8
• Chronic granulomatous disease (CGD)
• COPD
• Endometrial adenocarcinoma
• Endometrial clear cell adenocarcinoma
• Endometrial dedifferentiated carcinoma
• Endometrial endometrioid adenocarcinoma
• Endometrial mixed cell adenocarcinoma

Individuals with these conditions who are considering trial participation are encouraged to explore these options without delay, as enrollment opportunities will soon expire.

New Research Horizons: Asthma, Autism, and Cardiovascular Health

This month, Montana welcomed 3 new clinical trials, a positive shift from 0 new trials that opened in March 2026. These new studies offer fresh opportunities for Montanans to engage with cutting-edge research, addressing a range of health concerns from chronic conditions to developmental disorders.

One particularly notable new trial comes from major pharmaceutical sponsor Sanofi: NCT07556159. This study, titled "A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice," aims to enroll a substantial 2,500 participants. Its primary goal is to comprehensively describe the characteristics of individuals with asthma across different severities, examining sociodemographic and clinical factors, treatment approaches, disease burden, biomarkers, and both disease-specific and general health-related quality of life. This large-scale observational study provides an important opportunity for individuals with asthma to contribute to a deeper understanding of their condition.

Beyond asthma, the new trials are exploring a diverse set of conditions, reflecting a broad approach to medical research:

• Asthma
• Autism
• Autism spectral disorder
• Autism spectrum disorder
• Blood pressure
• Cardiovascular diseases
• Cholesterol
• Cholesterol, HDL
• Cholesterol, LDL
• Glycated hemoglobin (HbA1c)

These new studies are sponsored by a mix of industry and academic leaders. Black Tie Medical, Inc. and Sanofi represent industry contributions, while the University of Montana is leading an academic initiative. Of the new trials, 2 are sponsored by industry and 1 by an academic institution.

Montana's Expanding Research Footprint

Montana's clinical trial landscape continues to grow, with a total of 227 clinical trials currently recruiting across 18 cities and 115 research sites statewide. This broad distribution ensures that opportunities are accessible beyond major metropolitan areas.

This month's new trials have further diversified the state's research map. Missoula saw the launch of 2 new trials, reinforcing its role as a key research hub. Additionally, Hamilton welcomed 1 new trial, indicating a spread of research opportunities into other communities. This geographic distribution allows more Montanans to participate in studies closer to home.

The types of interventions being studied in these new trials are varied, offering different avenues for participation:

• BEHAVIORAL (2 trials)
• OTHER (2 trials)
• BIOLOGICAL (1 trial)
• DIETARY_SUPPLEMENT (1 trial)
• PROCEDURE (1 trial)

This variety means that participants might be involved in studies focusing on lifestyle changes, new biological treatments, dietary interventions, or specific medical procedures, depending on the trial's design.

Who Can Participate? Opportunities for Diverse Demographics

Clinical trials are designed to include a wide range of participants, ensuring that new treatments and insights are relevant to diverse populations. Of the 3 new trials launched this month, 2 are open to children, providing important opportunities for younger individuals to contribute to medical science. Additionally, 3 of the new trials include older adults, ensuring that the senior population has ample avenues to participate in research that directly impacts their health.

For individuals without a specific medical condition, opportunities to contribute to research are also available. While none of the 3 new trials this month are actively seeking healthy volunteers, there are still 21 total clinical trials currently recruiting healthy participants across Montana. These studies play a crucial role in establishing baseline data and understanding the effects of interventions in individuals without existing health issues.

As we move through spring, Montanans are encouraged to explore these diverse clinical trial opportunities, whether for specific conditions or as healthy volunteers, to contribute to the advancement of medical knowledge and future health solutions.